FDA Approves Wegovy to Help Prevent Heart Attack, Stroke
FRIDAY, March 8, 2024 -- Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death.“Wegovy is now...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cardiology | Diabetes | Endocrinology | Food and Drug Administration (FDA) | General Medicine | Heart | Heart Attack | Stroke | Weight Loss